Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_assertion type Assertion NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_head.
- NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_assertion description "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_provenance.
- NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_assertion evidence source_evidence_literature NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_provenance.
- NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_assertion SIO_000772 19809881 NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_provenance.
- NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_assertion wasDerivedFrom befree-20150227 NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_provenance.
- NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_assertion wasGeneratedBy ECO_0000203 NP974344.RAVyDLE3bFezlD6cqoB2QyVcnlS-bgiIR_WLw_CWO2-AM130_provenance.